Ketamine is a legal, safe and effective medicine used to treat a variety of mental health conditions, including depression, anxiety and PTSD. Ketamine has rapidly-acting antidepressant and mood-enhancing effects, which can begin to take effect within 1-2 hrs. after treatment and last for up to 2 weeks. It works by blocking the brain’s NMDA receptors as well as by stimulating AMPA receptors, which are thought to help form new synaptic connections and boost neural circuits that regulate stress and mood.

More Readings
Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR. The Potential of Psychedelics for End of Life and Palliative Care. Curr Top Behav Neurosci. 2022;56:169-184. doi: 10.1007/7854_2021_278. PMID: 34958455.
​https://pubmed.ncbi.nlm.nih.gov/34958455/

Bahji, A., Zarate, C. A., Vazquez, G. H. (2022). Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis. Expert Opin Drug Saf. (06/21/22). 853-866. DOI: 10.1080/14740338.2022.2047928 https://pubmed.ncbi.nlm.nih.gov/35231204/

Katzman, J. (2018). Rapid depression remission and the “therapeutic bends” with ketamine-assisted psychotherapy. Psychedelics Today.
https://www.healingrealmscenter.com/blog/rapid-depression-remission-and-the-therapeutic-bends

Bennett, R. (2019). Paradigms of ketamine treatment. MAPS Bulletin, 29(1).
https://maps.org/news/bulletin/articles/436-maps-bulletin-spring-2019-vol-29,-no-1/7718-paradigms-of-ketamine-treatment-spring-2019
Oaklander, M. (2017). New hope for depression. TIME.
https://time.com/magazine/us/4876068/august-7th-2017-vol-190-no-6-u-s/

Dore, J., Turnipseed, B., Dwyer, S., Turnipseed, A., Andries, J., Ascani, G., Monnette, C., Huidekoper, A., Strauss, N., & Wolfson, P. (2019). Ketamine assisted psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy, Journal of Psychoactive Drugs, 51(2), 189-198. DOI: 10.1080/02791072.2019.1587556
https://www.tandfonline.com/doi/full/10.1080/02791072.2019.1587556

CALL: 917-8338081

EMAIL: [email protected]

I am proud to partner with Journey Clinical, which has a specialized medical team that determines eligibility for KAP, prescribes the ketamine, & supports us in monitoring outcomes.

​